Nifty Remains RangeBound as Resistance at 23800 Caps Upside Momentum Healthcare and Tech Lead Broad Rally as SP 500 Inches Higher APEC Meeting Highlights Persistent USChina Trade Divergence Indian Equity Indices Show Mixed Signals Hind Zinc SBI Force Motors Among Most Traded Trump Signals No Rush on Iran Nuclear Deal Criticizes Opponents as Losers Singapore Benefits from Global AI Investment Surge but Faces Geopolitical Risks Says MTI DOO Q1 2026 Earnings EPS Beat Sparks Positive Market Reaction VRME Q4 2025 Earnings EPS Misses Estimates as Stock Edges Lower HZO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment THG Q1 2026 Earnings Strong EPS Beat Driven by Underwriting Discipline Shares Dip Slightly ICU Medical Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency CWK Q1 2026 Earnings EPS Beats Estimates Amid Commercial Real Estate Challenges NRG Energy Sheds 17 as Shares Test Key Support Levels Novagold Resources NG Holds Above Support Amid Gold Market Uncertainty Ryder System R Slips Slightly Consolidation Near Resistance Levels Credit Suisse Asset Management Income Fund Inc CIK Holds Steady at 252 Amid Narrow Trading Range Mitek Systems Edges Lower as Stock Tests Key Support Levels White House Announces Soybean and Rare Earth Deals After TrumpXi Summit China Signals Potential Tariff Reductions Portugals Meo Sues State for 82 Million Over Huawei 5G Equipment Ban Office Lunch Culture Shift From Corporate Luxury to Workplace Burden Fed Chair Kevin Warsh Signals Potential GreenspanInspired Monetary Policy Approach The Eye of the Storm How the WTOIMF Regulatory Gap May Fuel Currency Manipulation and Tariff Resurgence Pershing Square IPO Bill Ackmans Hedge Fund Plans Dual Stock Listing on NYSE Barclays Posts 18 Profit Surge and Upgrades FullYear Income Outlook DMC Global BOOM Q1 2026 Earnings NarrowerThanExpected Loss Surprises Estimates Serina Therapeutics Inc SER Recovers 493 as Stock Approaches Key Resistance at 208 GRCE Q1 2026 Earnings EPS Surprises to the Upside Despite No Revenue BNR Q3 2022 Earnings EPS Beat Expectations Amid Challenging Operating Environment PTON Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher Amid Operational Updates CHH Q1 2026 Earnings EPS Misses Estimates by 1967 as Stock Slips Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses NAUT Q1 2026 Earnings Narrowed Losses Beat Estimates Amid Platform Progress Ingevity NGVT Q1 2026 Earnings Strong EPS Beat Drives Stock Higher